Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Kooros Motamed-Larijani

Kooros Motamed-Larijani

NantBioscience Inc., USA


Kooros Motamed-Larijani has been the Director of Drug Development at Nant-Bioscience Inc. since April 2016. Previously, he served as VP of Strategic Alliances and Clinical Communications and VP of Clinical Development and Nanomedicine at Sorrento Therapeutics Inc. from 2013 to 2016. He also served as a co-founder and CSO/CTO of Igdrasol Inc. and Biomiga Diagnostics LLC start-up companies from 2011-2013. Prior to that, Dr. Motamed served as the MOA and Molecular Biology Group Head at Celgene Corp. and Abraxis Bioscience LLC. from 2007-2011. Dr. Motamed held an Assistant Professorship position in the Department of Pathology and Vascular Biology Center at Medical College of Georgia, Augusta from 2002-2007. He has over 30 original publications in peer-reviewed journals, over 50 conference presentations and 5 issued patents. He has served on the Editorial Board of Journal of Nanomaterials & Molecular Nanotechnology since 2013. Dr.Motamed received a B.S. degree in Biology from University of San Francisco and a Ph.D. degree from the University of California, Davis in Microbiology.


Abstract : The evolving landscape of biobetters: Advantages & challenges of being better